| abstract |
The present invention relates to a method for therapy control of patients and patients (sub) populations (responders / non-responders) with rheumatoid arthritis (RA) as well as the use of suitable marker sequences, in particular in the form of panels, diagnostics and test kits, and their use and application for the diagnosis, prognosis and therapy control of rheumatoid arthritis (RA), especially in the case of drug treatment. |